Patents Assigned to ROSEMAN UNIVERSITY OF HEALTH SCIENCES
  • Patent number: 10980932
    Abstract: The present invention is directed towards methods for therapeutically targeting circulating tumor cells during hemodialysis.
    Type: Grant
    Filed: February 26, 2016
    Date of Patent: April 20, 2021
    Assignee: Roseman University of Health Sciences
    Inventors: Thuc T. Le, Ranjana Mitra, Yasuyo Urasaki, Oscar B. Goodman
  • Patent number: 10617682
    Abstract: Embodiments relate to compositions comprising a prochlorperazine compound and a nasal carrier, including methods for formulating such compositions for pharmaceutical applications, for example, for treating or reducing the incidence of migraine headaches. Additional embodiments relate to articles comprising a prochlorperazine compound and a nasal carrier, including use of such articles as nasal drops or nasal sprays. Further embodiments relate to methods for using such articles, for example, for treating or reducing the incidence of migraines.
    Type: Grant
    Filed: May 31, 2018
    Date of Patent: April 14, 2020
    Assignee: Roseman University of Health Sciences
    Inventor: Venkata Kashyap Yellepeddi
  • Patent number: 10591478
    Abstract: The present invention is directed towards methods for treating non-alcoholic fatty liver disease (NAFLD) in a patient and determining prognosis of NAFLD in a patient.
    Type: Grant
    Filed: August 25, 2016
    Date of Patent: March 17, 2020
    Assignee: Roseman University of Health Sciences
    Inventors: Thuc T. Le, Yasuyo Urasaki, Ronald R. Fiscus
  • Publication number: 20180259515
    Abstract: The present invention is directed towards methods for treating non-alcoholic fatty liver disease (NAFLD) in a patient and determining prognosis of NAFLD in a patient.
    Type: Application
    Filed: August 25, 2016
    Publication date: September 13, 2018
    Applicant: Roseman University of Health Sciences
    Inventors: Thuc T. LE, Yasuyo URASAKI, Ronald R. FISCUS
  • Publication number: 20180104403
    Abstract: The present invention is directed towards methods for therapeutically targeting circulating tumor cells during hemodialysis.
    Type: Application
    Filed: February 26, 2016
    Publication date: April 19, 2018
    Applicant: ROSEMAN UNIVERSITY OF HEALTH SCIENCES
    Inventors: Thuc T. Le, Ranjana Mitra, Yasuyo Urasaki, Oscar B. Goodman